Kalendis Augusti 3-4, 2023, die 5 CMC-Sinae Sinarum Internationalis Biological & Chemical Pharmaceutical Expo anno 2023 habita est in Suzhou Internationalis Expo Centre, a Junda Articuli Venture coordinata et a Shenzhen Huarong sustentata. {490910}
Ut nationalis pharmaceuticae industriae professionalis conventus, colloquium includit innovationis fons potentiae Hall (C1 praetorium), aulae notae praeparationis (D1 praetorium), et aula primigenia et auxiliaris involucrum (E1 praetorium). Involving cell and gene therapy, antibody pharmaca, moleculae innovative medicaments, generic pharmaca, MAH B licentia, emendavit nova medicamenta, apis, synthetica biologiam, pharmaceuticam et praeparationem viridis CRO, CDMO cooperatio, invitata a regimine, industria, scientia. investigationis, oeconomicis, instrumentis aliisque campis peritorum medicorum, societatum pharmaceuticorum, collegae pharmaceutici ad sententiam commutandam. Per expo forum simul in tribus venues peractum est, millia conatibus interveniunt, plus quam trecenti convivae graves in scaenam de rebus incisis loquebantur, et in foro. the expo site was put together, which quite had the meaning of Jixian Academy et centum scholas cogitationis certandi. Hodie primus dies CMC-China Expo, scena discursum est. {490910}
Principes hospites expo repraesentabant D. Wang Bo, fundator Rongzhiyun, Dominus Tao Desheng, Vice Praeses Lizhu Group, Dominus Chi Cheng, Praeses Pharmaceuticae Asiae Orientalis, Dominus Ipse Dunwei, Praeses de Zezheng Pharmaceutical, et Dominus Cheng Zhigang, Praeses Hengdi Pharmaceuticae, in scaena simul ad magnam pompam deducendam pro expo! {490910}
![2-[(6-Chloro-3,4-Dihydro-3-Mehtyl-2,4-Dioxo-1(2h)-Pyrimidinyl)Methyl]Benzonitrile 334618-23-4](https://d.hzytb.com/images/20230727/150635/836899.jpg?imageView2/1/w/300/h/300 "2-[(6-Chloro-3,4-Dihydro-3-Mehtyl-2,4-Dioxo-1(2h)-Pyrimidinyl)Methyl]Benzonitrile 334618-23-4")
